Daniel P. Alford, MD, MPH is Professor of Medicine, Associate Dean of Continuing Medical Education and Director of the Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program at Boston University School of Medicine (BUSM). He is on staff in the Section of General Internal Medicine and director of the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center (BMC). He is also Medical Director of the Boston University Evidence-based SBIRT Student Training (BESST) Project and the Massachusetts SBIRT Training and Technical Assistance (MASBIRT TTA) program. He is past-president of the Association for Medical Education and Research in Substance Abuse (AMERSA). He was recognized as a Champion of Change by the White House. In 2014 he received the American Medical Association “Award for Health Education” and in 2016 was awarded the first Educator of the Year Award by the American Society of Addiction Medicine (ASAM) and the Award for Distinguished Contributions to Behavioral Medicine by the American College of Physicians (ACP). His clinical, educational and research interests focus on opioid use disorders and safe and competent opioid prescribing for chronic pain.
- Associate Dean, Continuing Medical Education, Boston University School of Medicine
- Director, Clinical Addiction Research and Education Unit, Medicine, Boston University School of Medicine
- BU Profile
- Safe and Competent Opioid Prescribing Education (SCOPE of Pain) Program
- Boston University School of Medicine CME office
- Immersion Training Program in Addiction Medicine
- CARE Unit Faculty
- Boston Medical Center Provider Profile
- Association for Medical Education and Research in Substance Abuse (AMERSA)
- Safe Opioid Prescribing Education Modules
- Safe Opioid Prescribing Resources
- Grayken Center for Addiction at Boston Medical Center
- Public Relations - BU Experts
- Boston University, MD
- Boston University, MPH
- Connecticut College, BA
- Marietta College, BA
- Published on 1/25/2021
Roseen EJ, Kasali BA, Corcoran K, Masselli K, Laird L, Saper RB, Alford DP, Cohen E, Lisi A, Atlas SJ, Bean JF, Evans R, Bussières A. Doctors of chiropractic working with or within integrated healthcare delivery systems: a scoping review protocol. BMJ Open. 2021 Jan 25; 11(1):e043754. PMID: 33495261.
- Published on 1/8/2021
Laks J, Alford DP, Patel K, Jones M, Armstrong E, Waite K, Henault L, Paasche-Orlow MK. A National Survey on Patient Provider Agreements When Prescribing Opioids for Chronic Pain. J Gen Intern Med. 2021 Mar; 36(3):600-605. PMID: 33420560.
- Published on 10/4/2020
Winhusen T, Walley A, Fanucchi LC, Hunt T, Lyons M, Lofwall M, Brown JL, Freeman PR, Nunes E, Beers D, Saitz R, Stambaugh L, Oga EA, Herron N, Baker T, Cook CD, Roberts MF, Alford DP, Starrels JL, Chandler RK. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study. Drug Alcohol Depend. 2020 12 01; 217:108325. PMID: 33091842.
- Published on 4/25/2020
Bertholet N, Meli S, Palfai TP, Cheng DM, Alford DP, Bernstein J, Samet JH, Lloyd-Travaglini C, Saitz R. Screening and brief intervention for lower-risk drug use in primary care: A pilot randomized trial. Drug Alcohol Depend. 2020 Apr 25; 213:108001. PMID: 32563116.
- Published on 1/1/2020
John RS, Salas-Wright CP, Amodeo M, Chassler D, Alford DP. Faculty education in addiction training (FEAT): Evaluating an online training program for multidisciplinary health professions educators. Subst Abus. 2020; 41(3):292-296. PMID: 32697174.
- Published on 11/27/2019
Levy S, Seale JP, Alford DP. Medicine, with a focus on physicians: Addressing substance use in the 21st century. Subst Abus. 2019; 40(4):396-404. PMID: 31774388.
- Published on 7/30/2019
Kertesz SG, Satel SL, DeMicco J, Dart RC, Alford DP. Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention. Subst Abus. 2019; 40(4):466-468. PMID: 31361588.
- Published on 5/17/2019
Kertesz SG, Satel SL, DeMicco J, Dart RC, Alford DP. Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention. Subst Abus. 2019; 40(1):4-6. PMID: 31100051.
- Published on 5/1/2019
Alford DP, Lazure P, Murray S, Hardesty I, Krause JR, White JL. National Trends in Prescription Opioid Risk Mitigation Practices: Implications for Prescriber Education. Pain Med. 2019 05 01; 20(5):907-915. PMID: 30789651.
- Published on 4/10/2019
Hamnvik OR, Alford DP, Ryan CT, Hardesty IT, Drazen JM. NEJM Knowledge+ Pain Management and Opioids - A New Adaptive Learning Module. N Engl J Med. 2019 04 18; 380(16):1576-1577. PMID: 30969501.
View 73 more publications: View full profile at BUMC